Adding IL-11 to G-CSF for faster blood cell recovery after transplant
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether adding a second drug (IL-11) to the standard G-CSF can help your blood cells recover faster after a stem cell transplant using your own cells. It is for people with multiple myeloma or lymphoma who are about to have this transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a new diagnosis of multiple myeloma or lymphoma
- You are a good candidate for a stem cell transplant using your own cells
- Your heart, lungs, and liver are working well enough for the transplant
- You are not pregnant or breastfeeding, and you don't have active HIV, hepatitis B, or hepatitis C
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a stem cell-mobilizing medicine (G-CSF) at a specific time of day based on your natural sleep/wake rhythm can improve the collection of blood stem cells from healthy donors. It aims to make the donation process more efficient and comfortable.
This study tests if adding Mozobil (a drug that helps release stem cells) before stem cell transplant can improve outcomes for people with multiple myeloma, Hodgkin's lymphoma, or non-Hodgkin lymphoma. If you are eligible, you will receive Mozobil along with standard stem cell mobilization medicines.
This study tests whether a drug called interleukin-7 (CYT107) can help your immune system recover faster and clear myeloma cells better after a stem cell transplant. You would receive CYT107 injections after your transplant, and the study will check if this improves your long-term outcome.
This trial compares giving a single dose of G-CSF versus splitting it into two doses to see which works better for collecting stem cells from healthy bone marrow donors. The goal is to find a simpler and possibly more comfortable way to help donors produce enough stem cells for transplant.
This trial tests if a natural compound called sulforaphane can help your blood cells recover faster after a cord blood transplant for high-risk blood cancers. If you qualify, you would receive this supplement along with your transplant.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
Hear when a new Hematopoetic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.